Sexual Side Effects of Zoloft (Sertraline)
Zoloft causes sexual dysfunction in a substantial proportion of patients, with the most common effects being ejaculation failure (8% in men), decreased libido (7% in men, 4% in women), and erectile dysfunction (4% in men). 1
Specific Sexual Side Effects by Gender
In Men:
- Ejaculation failure: 8% (vs 1% placebo)
- Decreased libido: 7% (vs 2% placebo)
- Erectile dysfunction: 4% (vs 1% placebo)
- Ejaculation disorder: 3% (vs 0% placebo)
- General male sexual dysfunction: 2% (vs 0% placebo)
In Women:
- Decreased libido: 4% (vs 2% placebo)
- Delayed or absent orgasm (specific rates underreported)
These rates come from pooled FDA clinical trials involving 3,066 adults across multiple psychiatric conditions 1.
Critical Context: Underreporting
The FDA label explicitly warns that these rates likely underestimate the true incidence because patients and healthcare providers are often reluctant to discuss sexual problems 1. Research suggests the actual rates may be substantially higher, with some studies reporting sexual dysfunction in over 70% of patients treated with sertraline 2.
Comparative Profile Among Antidepressants
Sertraline occupies a middle position for sexual side effects among second-generation antidepressants:
- Lower sexual dysfunction than paroxetine (which has the highest rates among SSRIs) 3, 4
- Higher sexual dysfunction than bupropion (which has significantly lower rates) 3, 4, 5
- Similar rates to fluoxetine 4
The 2016 ACP guideline specifically notes that bupropion is associated with lower rates of sexual adverse events than both fluoxetine and sertraline, while paroxetine has higher rates than sertraline 3.
Clinical Management Algorithm
When sexual dysfunction occurs on sertraline:
- Confirm the dysfunction is treatment-emergent (not pre-existing from the underlying depression)
- Consider dose reduction if clinically feasible without compromising efficacy
- Switch to bupropion if sexual function is a priority and depression severity allows 3, 4
- Discuss timing of onset - many sexual side effects are mild and transient, decreasing with continued treatment 6
Important Caveat: Post-SSRI Sexual Dysfunction (PSSD)
A small subset of patients experience persistent sexual dysfunction even after discontinuing sertraline 2, 7. This condition, known as post-SSRI sexual dysfunction, represents a serious long-term risk that should be discussed during informed consent.
Prescribing Recommendation
Before initiating sertraline, explicitly inquire about baseline sexual function and inform patients about the 4-8% risk of specific sexual side effects 1. The FDA label mandates this discussion because sexual symptoms are rarely spontaneously reported 1. Document this conversation to ensure patients can make informed decisions weighing antidepressant efficacy against quality of life impacts on sexual function.
For sexually active patients where this side effect profile is unacceptable, consider bupropion as first-line therapy instead, as it demonstrates equivalent antidepressant efficacy with significantly lower sexual dysfunction rates 3, 5.